How breast cancer patients respond to tamoxifen may be linked to the gut microbiome

Tar­sus Phar­ma­ceu­ti­cals has se­cured the FDA’s first ap­proval to treat ir­ri­tat­ed eyes caused by tiny mites, a con­di­tion known as de­mod­ex ble­phar­i­tis. The drug, to

Jeremy Faust is editor-in-chief of , an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is author